When Are Confirmatory Trials ‘Underway’? FDA Releases New Accelerated Approval Guidance

Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for confirmatory trials for therapies seeking the shortened path to market.